back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-19 12:19 Tx date 2025-03-17 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,150
+15,000 vol $4.01 each |
84,105 | |
| Filed 2024-05-15 11:31 Tx date 2024-05-13 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,100
+15,000 vol $3.94 each |
69,105 | |
| Filed 2023-08-23 12:58 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,000
+20,000 vol $4.70 each |
54,105 | |
| Filed 2022-12-15 15:17 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$31,250
+3,125 vol $10.00 each |
17,925 | |
| Filed 2022-12-15 15:16 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$67,130
+6,339 vol $10.59 each |
34,105 | |
| Filed 2021-12-10 15:02 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$28,000
+2,800 vol $10.00 each |
14,800 | |
| Filed 2021-12-10 15:00 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$61,135
+4,046 vol $15.11 each |
27,766 | |
| Filed 2021-03-19 08:41 Tx date 2021-03-17 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
12,000 | ||
| Filed 2021-03-19 08:40 Tx date 2021-03-17 |
$HLS
HLS Therapeutics Inc. |
Spence, David Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
23,720 |